Recruiting
Hypergammaglobulinaemia benign monoclonal+1
RecruitingRegistered drugNo placebo
A Study of Linvoseltamab in Adult Patients with High-Risk Monoclonal Gammopathy of Undetermined Significance or Non-High-Risk Smoldering Multiple Myeloma
Registered drugNo placebo
- Disease:Hypergammaglobulinaemia benign monoclonalPlasma cell myeloma
- Substances:DexamethasoneLinvoseltamab+4
Countries:
Belgium
Belgium- Participants:18–64 years · 65+ years
- Substances:Dexamethasone
- Sponsor:Regeneron Pharmaceuticals Inc.



